Chevy Chase Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $182M | Sell |
407,615
-748
| -0.2% | -$349K | 0.52% | 27 |
|
|
2025
Q4 | $185M | Sell |
408,363
-10,146
| -2% | -$4.37M | 0.5% | 27 |
|
|
2025
Q3 | $164M | Sell |
418,509
-22,418
| -5% | -$9.37M | 0.45% | 31 |
|
|
2025
Q2 | $196M | Sell |
440,927
-2,121
| -0.5% | -$977K | 0.57% | 26 |
|
|
2025
Q1 | $215M | Sell |
443,048
-1,653
| -0.4% | -$770K | 0.69% | 21 |
|
|
2024
Q4 | $179M | Sell |
444,701
-2,160
| -0.5% | -$1M | 0.55% | 26 |
|
|
2024
Q3 | $208M | Sell |
446,861
-6,568
| -1% | -$3.16M | 0.64% | 23 |
|
|
2024
Q2 | $213M | Buy |
453,429
+9,604
| +2% | +$4.17M | 0.68% | 21 |
|
|
2024
Q1 | $186M | Sell |
443,825
-1,124
| -0.3% | -$475K | 0.61% | 29 |
|
|
2023
Q4 | $181M | Buy |
444,949
+14,311
| +3% | +$5.29M | 0.65% | 26 |
|
|
2023
Q3 | $150M | Buy |
430,638
+14,744
| +4% | +$5.16M | 0.59% | 30 |
|
|
2023
Q2 | $146M | Buy |
415,894
+77,125
| +23% | +$26M | 0.55% | 33 |
|
|
2023
Q1 | $107M | Buy |
338,769
+122,740
| +57% | +$36.8M | 0.42% | 52 |
|
|
2022
Q4 | $62.4M | Buy |
216,029
+59,356
| +38% | +$18.1M | 0.27% | 96 |
|
|
2022
Q3 | $45.4M | Buy |
156,673
+2,149
| +1% | +$618K | 0.19% | 114 |
|
|
2022
Q2 | $43.5M | Buy |
154,524
+1,312
| +0.9% | +$351K | 0.18% | 126 |
|
|
2022
Q1 | $40M | Buy |
153,212
+462
| +0.3% | +$110K | 0.14% | 148 |
|
|
2021
Q4 | $33.5M | Sell |
152,750
-6,536
| -4% | -$1.27M | 0.11% | 174 |
|
|
2021
Q3 | $28.9M | Sell |
159,286
-5,666
| -3% | -$1.11M | 0.1% | 186 |
|
|
2021
Q2 | $33.3M | Sell |
164,952
-9,520
| -5% | -$1.99M | 0.11% | 173 |
|
|
2021
Q1 | $37.5M | Sell |
174,472
-14,332
| -8% | -$3.15M | 0.13% | 157 |
|
|
2020
Q4 | $44.6M | Sell |
188,804
-17,366
| -8% | -$3.98M | 0.16% | 147 |
|
|
2020
Q3 | $56.1M | Sell |
206,170
-15,023
| -7% | -$4.14M | 0.22% | 101 |
|
|
2020
Q2 | $64.2M | Sell |
221,193
-7,558
| -3% | -$2.05M | 0.26% | 87 |
|
|
2020
Q1 | $54.4M | Buy |
228,751
+2,526
| +1% | +$579K | 0.25% | 92 |
|
|
2019
Q4 | $49.5M | Sell |
226,225
-1,493
| -0.7% | -$302K | 0.19% | 125 |
|
|
2019
Q3 | $38.6M | Sell |
227,718
-464
| -0.2% | -$82.1K | 0.16% | 147 |
|
|
2019
Q2 | $41.8M | Sell |
228,182
-1,222
| -0.5% | -$214K | 0.17% | 132 |
|
|
2019
Q1 | $39.1M | Buy |
229,404
+2,476
| +1% | +$457K | 0.16% | 139 |
|
|
2018
Q4 | $37.6M | Sell |
226,928
-17,032
| -7% | -$2.95M | 0.18% | 126 |
|
|
2018
Q3 | $47M | Sell |
243,960
-4,440
| -2% | -$791K | 0.19% | 122 |
|
|
2018
Q2 | $42.2M | Buy |
248,400
+159
| +0.1% | +$24.6K | 0.18% | 129 |
|
|
2018
Q1 | $40.5M | Sell |
248,241
-4,775
| -2% | -$780K | 0.18% | 135 |
|
|
2017
Q4 | $37.9M | Sell |
253,016
-922
| -0.4% | -$137K | 0.16% | 146 |
|
|
2017
Q3 | $38.6M | Buy |
253,938
+5,763
| +2% | +$867K | 0.17% | 138 |
|
|
2017
Q2 | $32M | Buy |
248,175
+4,702
| +2% | +$566K | 0.15% | 160 |
|
|
2017
Q1 | $26.6M | Buy |
243,473
+8,933
| +4% | +$786K | 0.13% | 184 |
|
|
2016
Q4 | $17.3M | Buy |
234,540
+3
| +0% | +$244 | 0.09% | 251 |
|
|
2016
Q3 | $20.5M | Sell |
234,537
-4,450
| -2% | -$421K | 0.11% | 219 |
|
|
2016
Q2 | $20.6M | Buy |
238,987
+3,634
| +2% | +$314K | 0.11% | 213 |
|
|
2016
Q1 | $18.7M | Buy |
235,353
+32,721
| +16% | +$2.96M | 0.11% | 224 |
|
|
2015
Q4 | $25.5M | Buy |
202,632
+2,238
| +1% | +$270K | 0.15% | 158 |
|
|
2015
Q3 | $20.9M | Buy |
200,394
+7,682
| +4% | +$987K | 0.13% | 183 |
|
|
2015
Q2 | $23.8M | Buy |
192,712
+3,845
| +2% | +$485K | 0.14% | 177 |
|
|
2015
Q1 | $22.3M | Buy |
188,867
+7,734
| +4% | +$927K | 0.13% | 190 |
|
|
2014
Q4 | $21.5M | Buy |
181,133
+156
| +0.1% | +$17.6K | 0.13% | 184 |
|
|
2014
Q3 | $20.3M | Buy |
180,977
+12,420
| +7% | +$1.18M | 0.13% | 188 |
|
|
2014
Q2 | $16M | Sell |
168,557
-3,346
| -2% | -$235K | 0.11% | 211 |
|
|
2014
Q1 | $12.2M | Buy |
171,903
+1,557
| +0.9% | +$123K | 0.09% | 266 |
|
|
2013
Q4 | $12.7M | Buy |
170,346
+2,824
| +2% | +$197K | 0.09% | 241 |
|
|
2013
Q3 | $12.7M | Buy |
+167,522
| New | +$13.3M | 0.1% | 225 |
|
Other funds holding VRTX
VCM
VPM
Chevy Chase Trust's VRTX Position: Q1 2026 in Review
Chevy Chase Trust reduced its Vertex Pharmaceuticals (VRTX) stake by 0.18% in Q1 2026, selling an estimated $349K and leaving 407,615 shares worth $182M. The position accounts for 0.52% of the portfolio, ranked #27.
Chevy Chase Trust first reported a position in VRTX in Q3 2013 and has held it in 51 quarters since. The position peaked at $215M in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Chevy Chase Trust held 407,615 shares of Vertex Pharmaceuticals worth $182M as of Q1 2026.
- Chevy Chase Trust sold 748 Vertex Pharmaceuticals shares in Q1 2026, an estimated $349K.
- Vertex Pharmaceuticals made up 0.52% of Chevy Chase Trust's portfolio in Q1 2026, its #27 holding.
- Chevy Chase Trust first reported a position in Vertex Pharmaceuticals in Q3 2013 and has held it in 51 quarters since.
- Chevy Chase Trust's Vertex Pharmaceuticals position peaked at $215M in Q1 2025.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Chevy Chase Trust's 13F filing for Q1 2026, filed 15 May 2026.